Phase II Study of TKI258 in Advanced Urothelial Carcinoma (Q64709909)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Study of TKI258 in Advanced Urothelial Carcinoma |
clinical trial |
Statements
A Phase II Multi-center, Non-randomized, Open Label Study of TKI258 in FGFR3 Mutated and FGFR3 Wild Type Advanced Urothelial Carcinoma (English)
0 references
March 2010
0 references
April 2012
0 references
44
0 references
18 year
0 references